INSM NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Insmed Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 98.60 USD
-7.8% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -24.4% below the Trend Line and sits at 6.7% of its 52-week range. The latest completed week returned -7.8%, after a -11.6% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 29/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.

Setup score 23 out of 100
Latest Close 98.60 USD 31 Jul 2026
1W Return -7.8% latest completed week
4W Return -11.6% short-term follow-through
12W Return -2.7% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -7.8% Latest completed week; four-week move -11.6%. Indicator stack 28/41 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 29/100 conviction; expected move 13.9%. News sentiment 54/100 67 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -24.4% below the Trend Line and sits at 6.7% of its 52-week range. The latest completed week returned -7.8%, after a -11.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0412-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -11.6% over four weeks, -2.7% over 12 weeks, and -9.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-7.8%
4W-11.6%
12W-2.7%
26W-37.1%
52W-9.3%
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.62Latest activity-pressure read.
Pressure change22.1%Four-week change in activity pressure.
Leadership-38.54Latest relative-leadership reading.
RS change-14.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength3/100Blend of value, momentum, and quality. Underlying universe rank 98; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality11/100Profitability and accounting quality. Underlying universe rank 90; rank 1 is best.
Momentum28/100Medium-term price momentum. Underlying universe rank 73; rank 1 is best.
Growth89/100Revenue and earnings growth. Underlying universe rank 12; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
28.3x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-3.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
81.6%
Gross profit retained from each unit of revenue.
Operating margin
-134.2%
Operating profit retained from revenue.
Free-cash-flow margin
-102.5%
Free cash flow generated from revenue.
Return on invested capital
-94.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
115.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-3.6%
Net share repurchases relative to market value.
Shareholder yield
-3.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

INSM shows bullish options pressure with a 29/100 conviction score, put-call volume ratio of 0.55, expected move of 13.9%, and Sharemaestro trend signal inactive.

Conviction29/100
Expected move13.9%
Put/call volume0.55
Pressure34
Speculation8
Volatility92
Trend agreement14
Open options detail
Insider activity6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 67 relevant articles.

19 positive · 43 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move13.9%Nearest-chain priced movement where available.
52-week drawdown-53.7%Distance below the 52-week high.
13-week volatility8.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+11.8%Week of 3 Apr.
Worst week-23.9%Week of 8 May.
Latest week-7.8%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains3
Flat weeks0
Modest losses7
Sharp losses10
Recent vol8.7%13-week weekly-return volatility.
Base vol7.4%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew5.7% / -5.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.04; No reversal markers Factors11/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 81 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options40/100

INSM shows bullish options pressure with a 29/100 conviction score, put-call volume ratio of 0.55, expected move of 13.9%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 13.9% Sentiment54/100

Weighted news tone is neutral across 67 relevant articles.

Earnings Preview: Insmed to Report Financial Results Pre-market on August 06 Insiders6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202698.60 USD-7.8%130.3 USD85.62 USD-0.62-38.5412.3MOff
24 Jul 2026106.9 USD-1.3%133.0 USD85.12 USD-0.75-33.289.9MOff
17 Jul 2026108.3 USD-6.3%135.3 USD84.58 USD-0.84-33.6411.5MOff
10 Jul 2026115.6 USD3.6%137.5 USD84.02 USD-0.84-32.2712.8MOff
3 Jul 2026111.6 USD8.0%140.3 USD83.41 USD-0.79-33.5411.3MOff
26 Jun 2026103.4 USD7.9%143.3 USD82.82 USD-0.80-38.0022.3MOff
19 Jun 202695.80 USD-2.1%146.8 USD82.29 USD-0.90-45.2934.1MOff
12 Jun 202697.85 USD3.9%150.2 USD81.81 USD-0.93-42.9424.3MOff
5 Jun 202694.22 USD-11.9%153.4 USD81.31 USD-0.88-44.0218.5MOff
29 May 2026106.9 USD0.6%156.6 USD80.83 USD-0.80-39.3712.1MOff
22 May 2026106.2 USD-2.7%159.4 USD80.27 USD-0.76-37.9616.6MOff
15 May 2026109.1 USD7.7%161.1 USD79.71 USD-0.78-35.4129.4MOff
8 May 2026101.3 USD-23.9%163.0 USD79.13 USD-0.84-40.1127.7MOff
1 May 2026133.3 USD-1.4%165.1 USD78.60 USD-0.85-16.866.9MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.